Caricamento...
SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy
BACKGROUND: Reinfection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been documented, raising public health concerns. SARS-CoV-2 reinfections were assessed in a cohort of antibody-positive persons in Qatar. METHODS: All SARS-CoV-2 antibody-positive persons from April 16...
Salvato in:
| Pubblicato in: | EClinicalMedicine |
|---|---|
| Autori principali: | , , , , , , , , , , , , , , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8079668/ https://ncbi.nlm.nih.gov/pubmed/33937733 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eclinm.2021.100861 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|